Average Co-Inventor Count = 6.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (15 from 3,681 patents)
15 patents:
1. RE47929 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
2. 10526321 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
3. 10308652 - Tricyclic heterocyclic compounds useful as inhibitors of TNF
4. 10000480 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
5. 9505748 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
6. 9315494 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
7. 9221826 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
8. 8987268 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
9. 8921368 - Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
10. 8404689 - Heterocyclic amide compounds useful as kinase inhibitors
11. 7935696 - Heterocyclic amide compounds useful as kinase inhibitors
12. 7923556 - Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
13. 7723336 - Fused heterocyclic compounds useful as kinase modulators
14. 7642257 - Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
15. 7419978 - Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors